Aquestive Therapeutics Inc (AQST) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Aquestive Therapeutics, Inc. (AQST)
Last aquestive therapeutics, inc. earnings: 3/11 04:30 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.aquestive.com/investor-relations
Company Research
Source: Yahoo! Finance
Positive Points Aquestive Therapeutics Inc ( NASDAQ:AQST ) has begun the FDA filing process for its Afilm epinephrine sublingual film, with expectations for NDA acceptance by June 2025. The company is on track to launch Anafilm in the first quarter of 2026, aligning with the allergy season, which could enhance market penetration. Pediatric studies for Anafilm have progressed as expected, with data supporting a product label similar to existing EpiPen autoinjectors. Aquestive Therapeutics Inc ( NASDAQ:AQST ) has strengthened its balance sheet by raising over $78 million from institutional healthcare investors. The company is preparing for potential international market expansion, targeting submissions in the EU, UK, and Canada. Negative Points Total revenue decreased by 10% in Q4 2024 compared to Q4 2023, primarily due to declines in license and royalty revenue. Research and development expenses increased significantly, driven by clinical trial costs for NFLM and AQST
Show less
Read more
Impact Snapshot
Event Time:
AQST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AQST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AQST alerts
High impacting Aquestive Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
AQST
News
- Aquestive Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswire
- Jim Cramer on Aquestive Therapeutics: “I Think It's a Very Interesting Spec” [Yahoo! Finance]Yahoo! Finance
- Looking at the Narrative for Aquestive Therapeutics After Patent Wins and FDA Milestones [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics, Inc. (NASDAQ:AQST) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.10 [Yahoo! Finance]Yahoo! Finance
- Aquestive Therapeutics (NASDAQ:AQST) had its price target raised by analysts at Piper Sandler from $5.00 to $8.00. They now have an "overweight" rating on the stock.MarketBeat
AQST
Earnings
- 11/5/25 - Miss
AQST
Sec Filings
- 12/5/25 - Form 4
- 12/4/25 - Form 4
- 11/17/25 - Form 144
- AQST's page on the SEC website